Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients already at risk for the disease.
Read the complete notice here:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/16949a-eng.php
